NTT Research appoints Iris Shelly as MEI laboratory scientist

SUNNYVALE, Calif .– (COMMERCIAL THREAD) – NTT Research, Inc., a division of NTT (TYO: 9432), today announced that it has appointed Iris Shelly as a scientist in its medical and health informatics (MEI) laboratory. Shelly, an applied research engineer with expertise in biomedical signal processing and low power devices, joined NTT Research in June 2021. She was most recently a senior applied research engineer at BIOTRONIK / Micro Systems Engineering, Inc. where she designed, developed and validated cardiac arrhythmia detection algorithms. Shelly brings this experience to the MEI Lab where she will first work on the model architecture and interface of the bionumeric twins initiative. Following Shelly’s initial research priorities, she will work on several other aspects of the bionumeric twins initiative, including disease-related aspects of the model.

“The MEI Lab is pleased to welcome Iris Shelly to its research team,” said Dr. Jon Peterson, MEI Lab Principal Scientist, responsible for advancing the bionumeric twin development strategy. “Shelly’s strong software background and strong skills in C #, algorithm design, Git, code review, machine learning, digital signal processing and more aligns strongly with the expertise needed to carry out the lab’s mission. MEI to apply bioinformatics and data science to medical research. Her background in biomedical engineering, her collaborative personality and innate curiosity, along with the skills mentioned above, position her as a key contributor to our research on bionumeric twins.

The goal of MEI Lab’s bionumeric twin initiative is to create complex digital replicas of human bodies that doctors can use to simulate various treatments. The objective is to allow optimal and patient-specific therapy, essential for exceptional care and well-being. Shelly’s work at NTT Research will contribute to the first phase of this project, the development of a cardiovascular bionumeric twin (CV BioDT). Shelly’s experience in algorithm design and attention to detail, honed through years of experience in medical device research and software verification, are essential skills in supporting the development of models for the CV BioDT.

“I am honored to join a team of renowned scientists, all dedicated to the advancement of medical and health sciences,” said Shelly. “By addressing the growing complexity of underlying diseases while helping determine the best cure from an ever-growing range of treatment options, MEI Lab’s Bionumeric Twin Initiative has the very real potential to make a difference. in people’s lives. I am delighted to bring my expertise in software development and biomedical engineering to contribute to this rewarding initiative. ”

In addition to designing, developing and validating cardiac arrhythmia detection algorithms at BIOTRONIK / Micro Systems Engineering, Inc., Shelly was also responsible for managing the datasets for the development and validation of the algorithms using preclinical and clinical signals, writing technical documentation to support FDA device approval and monitoring real-world clinical data and device performance in the field. Shelly also brings to NTT Research her experience in systems verification, hardware and software development, testing of product and system requirements for implantable medical devices and more. She holds a Master of Science in Electrical Engineering from Portland State University and a Bachelor of Science in Biomedical Engineering from Washington University in St. Louis.

Shelly’s appointment as MEI Lab Scientist follows a strategic joint research agreement with the National Cerebral and Cardiovascular Center (NCVC) of Japan to develop computational models related to cardiovascular disease, implement them on a platform. form bionumeric twins and develop applications for use by doctors and patients. The MEI Lab also announced earlier this year the addition of Dr. Jon Peterson to its team as a senior scientist. Dr Peterson, a biomedical engineer with both academic and medical device industry experience, will bring technical expertise and leadership to advance the development strategy for bionumeric twins.

In addition to the bionumeric twins initiative, the MEI Lab is also focusing on nanosensor technology. In August 2020, NTT Research announced the opening of an office in Munich in support of a joint research agreement with the Technical University of Munich (TUM), which links the MEI lab to the neuroelectronics group within from the TUM School of Bioengineering. The MEI Lab believes that the development of the bionumeric twin will be informed not only by a vast array of biological, physiological, genomic, phenotypic and health data, but also by data gleaned from portable and advanced nanosensor devices.

About NTT Research

NTT Research opened its offices in July 2019 as a new Silicon Valley startup to conduct fundamental research and advance technologies that drive positive change for humanity. Currently, three laboratories are housed at NTT Research’s facilities in Sunnyvale: the Physics and Informatics Laboratory (PHI), the Cryptography and Information Security Laboratory (CIS), and the Medical Informatics and Computing Laboratory. health (MEI). The organization aims to improve reality in three areas: 1) quantum information, neuroscience and photonics; 2) cryptographic and information security; and 3) medical and health informatics. NTT Research is part of NTT, a global provider of technology and business solutions with an annual R&D budget of $ 3.6 billion.

NTT and the NTT logo are registered trademarks or trademarks of NIPPON TELEGRAPH AND TELEPHONE CORPORATION and / or its affiliates. All other product names referenced are trademarks of their respective owners. © 2021 NIPPON TELEGRAPH AND TELEPHONE CORPORATION

Margie D. Carlisle